U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686406) titled 'IBD Biomarker Discovery and Validation Platform' on April 03.
Brief Summary: The goal of this observational study is to establish a multicenter prospective clinical and biospecimen platform for biomarker discovery and validation in inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
Researchers want to learn whether candidate biomarkers or combined biomarker models can help assess intestinal inflammation, monitor response to routine clinical treatment, predict treatment outcomes, and identify participants who may be at higher risk of disease progression.
The study may enroll participants with inflammatory ...